Replies to post #12177 on Todos Med Ltd (TOMDF)

[delerious1]

That's quite a brilliant future for TOMDF.

[freegriff]

$500M market cap definitely in the cards

[JPetroInc]

$0.40 pps...from $0.0175...?

a 23 x bagger - boy oh boy - that would be some magic show



AJMHO

[vcf5502]

redspeed,
You are more than entitled to your opinion but forty cents right now is just a pipedream as this ticker can't even maintain 4 cents when it gets there.

I've said it before and will say it again. This ticker will never make an appreciable move until we hear Dr.Siegel on FOX, Dr. Lapook on CBS, or Dr.Ashton on ABC etc , etc say the word TODOS on a national news broadcast. And that will only occur if there is approval of Tollovid for long Covid, or EUA for Tollovir for severe/hospitalized covid patients.

Any other spokespeople, influencers etc will not move the SP, as we have witnessed recently. There have been multiple positive releases and no upward movement of SP.

Also, remember that if the SP does begin to move and all notes convert. the outstanding share count will be just shy of 2 billion. That's a lot of paper.

So, I will use this as a "play" for now. Maybe pick up a few more shares if price lowers some more but only with the intention of unloading if there is a mini-spike. Keep lowering my breakeven at this point.

Many of you will disagree, I'm sure.

ALL IN MY OWN OPINION of course.

[redspeed]

My scenario #1 might be the front runner which is why it's my favorite.

Gerald Commissiong@G_Commish 5m
Not everyone is scaling back. @provistadx we are adding capacity

Why would you need to add capacity of you can ready do 175K test a week and generate $910M/year revenue using 'simple math' if you run at full capacity using ultra conversative reimbursement cost?

Now keep in mind Todos may NEVER generate almost $1B/yr revenue at Provista in a year.

Or they might. I like the risk to reward ratio and the perfect storm that is now setup. Wait until people figure out the pandemic is far from over. Calm before the storm.

[redspeed]

Update on the...

at least 4 ways to get to a $500M market cap I wrote about on Sunday

I think horse #4 'Tollovid' just overtook #1 Provista, but the latter is still coming on strong...

I like how in the video, the guy said Tollovid would be in stores and now we know, top stores.

I actually think there is a possibility of the stock getting to $0.40

That would be a $476,000,000 market cap that is obtainable a number of different ways to me but obviously not today and some things need to happen.

1. Provista Revenue - IF they can get to a fully loaded 175,000 test a week, just using a super conservative reimbursement cost of $100 per test would bring in $17.5M of revenue a week. That's $910M a year using 'simple math'.
A couple of other factors. They could double capacity if they need to. Also anything but the PCR Covid test would be higher than $100. I think GC may have given a cost on one of the other tests. I forget if it was $800.

2. Long Covid - Get the trials going and if Tollovid/r shows the same success they are seeing in the case studies, and I think the stock is an instant $500M market cap or higher

3. Tollovir - Get the Phase II extension going for hospitalized patients. Doesn't have to finish for shareholders to know the results since it's open label and data will flow throughout the trial. Show success and a $500M market cap or higher. Get an EUA, $1B+ Cap.

4. Tollovid - I think at some point this could go viral. We know it works. The issue is the whole world doesn't know about it yet, harder to buy outside of US and perception of it being expensive even though much cheaper than an ER visit or having Long Covid and can't work.

Sales would have to be pretty high to justify a $500M cap, but not that high if it goes Viral and people start thinking, finally a solution for Covid and no one else and anything except Pfizer that sort of works for some people.

So there are 4 scenarios where any one could fetch a $500M cap or higher. Certainly risk there as well. What I've been doing is not looking at them individually but as a whole. What if in the short-term (Q4) progress is make in each of these area and each contribute to getting to $500M cap?

btw, I really like #1. I think the revenue Provista will generate in Q4 and Q1 isn't even on anyone's radar.

My take is the BOD, GC and the leadership team knows how successful these scenarios can/will be which is why they are preparing for an uplist. Obviously if none of these happen DON"T UPLIST.